New Alzheimer’s Drug
Top of Mind with Julie Rose - Radio Archive, Episode undefined
- Jun 29, 2021 8:00 pm
- 17:10 mins
A new drug for Alzheimer’s is stirring up controversy on multiple fronts. The FDA approved it despite their own advisory committee saying there wasn’t enough evidence that the drug actually worked. And the drug’s $56,000 annual price tag is raising eyebrows. Medicare could bear the brunt of the new drug’s costs. Vanderbilt University School of Medicine health policy professor Stacie Dusetzina studies drug pricing.